- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05798000
Effect of WHO Surgical Safety Checklist and Anesthesia Equipment Checklist on Patients Outcomes in Low-resource Settings.
March 22, 2023 updated by: Kateryna Bielka, Bogomolets National Medical University
Effect of WHO Surgical Safety Checklist and Anaesthesia Equipment Checklist on Patients Outcomes in Low-resource Settings.
The study to investigate the effectiveness and the current perception of safety checklists in Ukrainian hospitals.
Study Overview
Status
Completed
Conditions
Detailed Description
A prospective multicenter study was conducted in 6 large Ukrainian hospitals: Kyiv City Clinical Hospitals #1, University Clinic of the Bogomolets National Medical University, Kyiv City Maternity Hospital #5, National Cancer Institute, Shalimov National Institute of Surgery and Transplantology, Saint Martin Hospital in Mukachevo.
Institutions were selected among those, where surgical department administration was willing to implement the Safe Surgery Saves Lives campaign recommendations, but has not yet formally introduced the WHO Safe Surgery Checklist.
On each study site, 1 or 2 operating rooms were designated for data collection.
All surgical procedures observed by the data collectors in those operating rooms were included.
The study was conducted in two phases: control period, lasting from February 1, 2022 until August 1, 2022, followed by a week-long educational period during which the WHO Surgical Safety Checklist and the Anesthesia Equipment Checklist were used but no data were collected.
The intervention period began on August 8, 2022 and lasted until December 31, 2022.
Hospital administration and members of all surgical teams were informed of the nature of the study and the proper checklist use method by the involved anesthesiologists, who were previously instructed by the primary investigators.
WHO Surgical Safety Checklists and the Anesthesia Equipment Checklists were provided in the designated operating rooms.
Both checklists were translated into Ukrainian.
The requirement for written informed consent from the patient was waived by the ethical committee of Bogomolets National Medical University.
The study design was approved by the ethics committee of the Bogomolets National Medical University (protocol #148, 07.09.2021).
Study Type
Observational
Enrollment (Actual)
2200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kyiv, Ukraine
- Bogomolets NMU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Institutions, where surgical department administration was willing to implement the Safe Surgery Saves Lives campaign recommendations but has not yet formally introduced the WHO Safe Surgery Checklist.
Description
Inclusion Criteria:
- medical institutions with surgical departments
Exclusion Criteria:
- medical institutions without surgical departments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Control
The control group without WHO and equipment checklist used
|
|
Study
Other group, where WHO safety check-list and equipment check-list were implemented
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recorded critical incidents during the procedure
Time Frame: 24 hours
|
Recorded critical incidents during the procedure (hypotension, hypertension etc.)
|
24 hours
|
|
Mortality
Time Frame: 28 days
|
Postoperative mortality during 28 days after surgery
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative complications
Time Frame: 1 months
|
Postoperative complications (bleeding, surgical infection etc.)
|
1 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Kateryna Bielka, PhD, Bogomolets National Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Schwendimann R, Blatter C, Luthy M, Mohr G, Girard T, Batzer S, Davis E, Hoffmann H. Adherence to the WHO surgical safety checklist: an observational study in a Swiss academic center. Patient Saf Surg. 2019 Mar 12;13:14. doi: 10.1186/s13037-019-0194-4. eCollection 2019.
- Sendlhofer G, Mosbacher N, Karina L, Kober B, Jantscher L, Berghold A, Pregartner G, Brunner G, Kamolz LP. Implementation of a surgical safety checklist: interventions to optimize the process and hints to increase compliance. PLoS One. 2015 Feb 6;10(2):e0116926. doi: 10.1371/journal.pone.0116926. eCollection 2015. Erratum In: PLoS One. 2015;10(4):e0123726.
- Bergs J, Hellings J, Cleemput I, Zurel O, De Troyer V, Van Hiel M, Demeere JL, Claeys D, Vandijck D. Systematic review and meta-analysis of the effect of the World Health Organization surgical safety checklist on postoperative complications. Br J Surg. 2014 Feb;101(3):150-8. doi: 10.1002/bjs.9381.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
March 22, 2023
First Submitted That Met QC Criteria
March 22, 2023
First Posted (Actual)
April 4, 2023
Study Record Updates
Last Update Posted (Actual)
April 4, 2023
Last Update Submitted That Met QC Criteria
March 22, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- GF230548
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Safety Issues
-
Shenyang Sunshine Pharmaceutical Co., LTD.Recruiting
-
Chulalongkorn UniversityNot yet recruiting
-
IC-MedTech CorporationCompleted
-
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics...Active, not recruiting
-
Mansoura UniversityCompleted
-
Showa Inan General HospitalCompleted
-
Asmaa Elwan Mohammed HassanCompleted
-
Hadassah Medical OrganizationGals Bio Ltd.Withdrawn
-
Federico II UniversityCompleted
-
Institute of Nuclear Energy Research, TaiwanCompleted